TCEAL7 and ovarian carcinoma: Downregulation of TCEAL7 enhances the expression levels of proliferative, angiogenic, inflammatory and anti-apoptotic genes in ovarian cancer cells through the nuclear factor kappa B (NF-κB) pathway [3].